Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer

被引：0
|
作者：
David O Azorsa
Irma M Gonzales
Gargi D Basu
Ashish Choudhary
Shilpi Arora
Kristen M Bisanz
Jeffrey A Kiefer
Meredith C Henderson
Jeffrey M Trent
Daniel D Von Hoff
Spyro Mousses
机构：
[1] The Translational Genomics Research Institute,Pharmaceutical Genomics Division
[2] Scottsdale,Genetic Basis of Human Disease Division
[3] The Translational Genomics Research Institute,Clinical Translational Research Division
[4] The Translational Genomics Research Institute,undefined
来源：
Journal of Translational Medicine | / 7卷
关键词：
Pancreatic Cancer; Gemcitabine; Pancreatic Cancer Cell; Pancreatic Cancer Cell Line; Axitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
    Azorsa, David O.
    Gonzales, Irma M.
    Basu, Gargi D.
    Choudhary, Ashish
    Arora, Shilpi
    Bisanz, Kristen M.
    Kiefer, Jeffrey A.
    Henderson, Meredith C.
    Trent, Jeffrey M.
    Von Hoff, Daniel D.
    Mousses, Spyro
    JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [2] Application of synthetic lethal RNAi screening for the identification of genes that modulate gemcitabine response in human pancreatic cancer cells
    Henderson, Meredith
    Arora, Shilpi
    Gonzales, Irma
    Choudhary, Ashish
    Kiefer, Jeffrey
    Trent, Jeffrey
    Mousses, Spyro
    Azorsa, David
    CANCER RESEARCH, 2009, 69
  • [3] A synthetic lethal screen identifies genetic determinants for gemcitabine sensitivity in pancreatic cancer
    Landry, Jerome C.
    Pantazides, Brooke G.
    Park, Wungki
    Shelton, Joseph W.
    Maithel, Shishir K.
    El-Rayes, Bassel
    Yu, David S.
    CANCER RESEARCH, 2012, 72
  • [4] A Synthetic Lethal Screen Identifies Genes That Mediate Gemcitabine Resistance in Pancreatic Cancer
    Pantazides, B.
    Hardy, C.
    Gandhi, K.
    Landry, J.
    Shelton, J.
    Maithel, S.
    El-Rayes, B.
    Kowalski, J.
    Yu, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S88 - S88
  • [5] A large-scale synthetic lethal RNAi screening identifies unique sensitizing targets for anti-inflammatory C000-Me in metastatic melanoma
    Ekmekcioglu, Suhendan
    Qin, Yong
    Deng, Wuguo
    Grimm, Elizabeth A.
    CANCER RESEARCH, 2012, 72
  • [6] A functional genomics approach using high-throughput RNAi to identify genes as gemcitabine sensitizing targets in pancreatic cancer
    Azorsa, David O.
    Azorsa, O.
    Basu, Gargi D.
    Monzon, Irma G.
    Trent, Jeffrey M.
    Von Hoff, Daniel D.
    Mousses, Spyro
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3489S - 3490S
  • [7] Genome-Wide RNAi Screening Identified Lethal Giant Larvae 1 as a Gemcitabine-Sensitizing Gene in Pancreatic Ductal Adenocarcinoma
    Zhu, Y.
    Chen, Y.
    PANCREAS, 2014, 43 (08) : 1429 - 1429
  • [8] Lethal and Bortezomib-Sensitizing Targets in Myeloma Identified by Genome-Scale RNAi Screening
    Tiedemann, R. E.
    Zhu, Y. X.
    Schmidt, J.
    Shi, C. X.
    Yin, H.
    Que, Q.
    Mousses, S.
    Stewart, A. K.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S141 - S142
  • [9] A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells
    Bhattacharjee, V.
    Zhou, Y.
    Yen, T. J.
    CELL CYCLE, 2014, 13 (24) : 3839 - 3856
  • [10] High-throughput RNAi screening identifies sensitizing targets to improve doxorubicin chemotherapy.
    Azorsa, DO
    Kiefer, JA
    White, ML
    Rojanapraparn, P
    Caplen, NJ
    Kallioniemi, O
    Mousses, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 845S - 845S
12345